Industry News
Pharmaceutical Industry News
With midphase data in hand, MediPrint lands investment to take drug delivery contact lens deeper into the clinic
With midphase data in hand, MediPrint lands investment to take drug delivery contact lens deeper into the clinic ntaylor Tue, 03/22/2022 - 06:11
Vallon’s abuse-resistant Adderall fails clinical trial, causing stock to crater
Vallon's abuse-resistant Adderall fails clinical trial, causing stock to crater ntaylor Tue, 03/22/2022 - 06:05
Novavax adamant its COVID shot will reach vaccine hesitant in Europe but wary of war’s impact
Novavax adamant its COVID shot will reach vaccine hesitant in Europe but wary of war's impact badams Tue, 03/22/2022 - 04:35
After price deal, Takeda’s lung cancer drug Exkivity wins UK green light ahead of J&J rival
After price deal, Takeda's lung cancer drug Exkivity wins UK green light ahead of J&J rival kdunleavy Mon, 03/21/2022 - 12:33
After price deal, Takeda’s lung cancer drug Exkivity wins UK green light
After price deal, Takeda's lung cancer drug Exkivity wins UK green light kdunleavy Mon, 03/21/2022 - 12:33
As AstraZeneca sounds the slowdown alarm in China, Jefferies beats the drum for growing branded drug market
As AstraZeneca sounds the slowdown alarm in China, Jefferies beats the drum for growing branded drug market aliu Mon, 03/21/2022 - 11:56
Recro Pharma rebrands itself as Societal CDMO in wake of Irisys purchase
Recro Pharma rebrands itself as Societal CDMO in wake of Irisys purchase jkeenan Mon, 03/21/2022 - 10:43
Wockhardt, Serum Institute of India to build UK fill-finish plant in Wales
Wockhardt, Serum Institute of India to build UK fill-finish plant in Wales jkeenan Mon, 03/21/2022 - 09:57
Cancer giants BMS, AstraZeneca clash in new checkpoint inhibitor patent suit
Cancer giants BMS, AstraZeneca clash in new checkpoint inhibitor patent suit esagonowsky Mon, 03/21/2022 - 09:42
Eli Lilly CEO’s pay falls 9% to $21.5M—no thanks to pension declines
Eli Lilly CEO's pay falls 9% to $21.5M—no thanks to pension declines aliu Mon, 03/21/2022 - 07:43
Facing generic rivals, Ipsen starts $66M Somatuline autoinjector project
Facing generic rivals, Ipsen starts $66M Somatuline autoinjector project ntaylor Mon, 03/21/2022 - 04:46
Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition
Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition kdunleavy Fri, 03/18/2022 - 18:13
Pfizer CEO scored big raise—to $24M—as drugmaker played a leading role in pandemic fight
Pfizer CEO scored big raise—to $24M—as drugmaker played a leading role in pandemic fight esagonowsky Fri, 03/18/2022 - 14:40
Pfizer gets an A on equality scorecard on Equal Pay Day
Pfizer gets an A on equality scorecard on Equal Pay Day sharon.coey Fri, 03/18/2022 - 12:06
After Pfizer’s pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submission
After Pfizer's pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submission kdunleavy Fri, 03/18/2022 - 11:16
As HAE offerings from Takeda and BioCryst gain steam, a doc survey offers lessons for the long term: analyst
As HAE offerings from Takeda and BioCryst gain steam, a doc survey offers lessons for the long term: analyst aliu Fri, 03/18/2022 - 10:35
Pfizer’s deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovid
Pfizer's deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovid kdunleavy Fri, 03/18/2022 - 09:33
Fierce Pharma Asia—Eisai’s reduced Aduhelm role; Chinese biotechs’ US delisting risks; Zai Lab’s new COO from Lilly
Fierce Pharma Asia—Eisai's reduced Aduhelm role; Chinese biotechs' US delisting risks; Zai Lab's new COO from Lilly aliu Fri, 03/18/2022 - 06:28
Pharma’s ‘superhero’ image fades as inflation, Ukraine drown out the industry
Pharma's 'superhero' image fades as inflation, Ukraine drown out the industry badams Fri, 03/18/2022 - 04:44
Amid sales slump, Teva CEO Schultz’s pay falls 7% to $14.7M
Amid sales slump, Teva CEO Schultz's pay falls 7% to $14.7M kdunleavy Thu, 03/17/2022 - 19:38